5‐lipoxygenase‐activating protein is an arachidonate binding protein
- 8 March 1993
- journal article
- Published by Wiley in FEBS Letters
- Vol. 318 (3) , 277-281
- https://doi.org/10.1016/0014-5793(93)80528-3
Abstract
5-Lipoxygenase-activating protein (FLAP) is an 18-kDa integral membrane protein which is essential for cellular leukotriene (LT) synthesis, and is the target of LT biosynthesis inhibitors. However, the mechanism by which FLAP activates 5-LO has not been determined. We have expressed high levels of human FLAP in Spodoptera frugiperda (Sf9) insect cells infected with recombinant baculovirus, and used this system to demonstrate that FLAP specifically binds [125I]L-739,059, a novel photoaffinity analog of arachidonic acid. This binding is inhibited by both arachidonic acid and MK-886, an LT biosynthesis inhibitor which specifically interacts with FLAP. These studies suggest that FLAP may activate 5-LO by specifically binding arachidonic acid and transferring this substrate to the enzyme.Keywords
This publication has 21 references indexed in Scilit:
- Pharmacology of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)-indol-2-yl]-2,2-dimethyl propanoic acid), a potent, orally active leukotriene biosynthesis inhibitorCanadian Journal of Physiology and Pharmacology, 1992
- Stimulation of leukotriene production and membrane translocation of 5-lipoxygenase by cross-linking of the IgE receptors in RBL-2H3 cellsBiochemistry, 1992
- Influx of extracellular calcium is required for the membrane translocation of 5-lipoxygenase and leukotriene synthesisBiochemistry, 1991
- Leukotrienes and Other Products of the 5-Lipoxygenase PathwayNew England Journal of Medicine, 1990
- Inhibitory effects of MK‐886 on arachidonic acid metabolism in human phagocytesBritish Journal of Pharmacology, 1990
- Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesisNature, 1990
- Identification and isolation of a membrane protein necessary for leukotriene productionNature, 1990
- L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitorCanadian Journal of Physiology and Pharmacology, 1989
- Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological EffectsScience, 1987
- The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology.Journal of Clinical Investigation, 1984